Breast augmentation is the most common aesthetic operation performed in the United States, reaching 329,914 procedures in 2018, with an increase of 15.2 percent compared to 2014. 1 Worldwide, 1,862,506 breast augmentation procedures were performed in 2018, an increase of 27.6 percent during the same period. 2 This procedure has been performed on women younger than 34 years in 56.7 percent of cases, 2 which means that they potentially have many years of life with the prosthesis. The most common indication for breast implants is augmentation, followed by reconstruction, usually after breast cancer treatment. 3 In the United States, the silicone smooth prosthesis is used the most, mainly from the following three manufacturers: Sientra (Santa Barbara, Calif.), Mentor (Irvine, Calif.), and Allergan (Irvine, Calif.). 4,5 In contrast, textured implants are more common in Europe. 4,5 Silicone-filled, saline-filled, and polyvinylpyrrolidone-hydrogel-filled implants are on the market. Silicone breast implants from the French manufacturer Poly Implant Prothèse were recalled from the European market after identification that the implants contained non-medical-grade silicone filler. In December of 2011, facing a large increase in the reported rupture rate and a possible cancer risk, in France, it was recommended that explantation of Poly Implant Prothèse devices be considered, regardless of their condition. 6 Therefore, there has been an increase in explantation procedures in the past decade, which has contributed to the present study.Besides this specific episode, reoperation for breast implant explantation mainly occurs when women desire an aesthetic change and have signals and symptoms of capsular contracture and implant bleeding or rupture, such as pain, palpable masses, and asymmetry. The leading theory on the pathogenesis of capsular contracture includes the alignment and contraction of fibroblasts within the capsule that forms around a breast implant. 5 The ruptured implants can be differentiated as "intracapsular" and "extracapsular." An intracapsular rupture is defined as a rupture of the implant shell, with an intact inflammatory